These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

833 related items for PubMed ID: 10190783

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Current management of unresectable non-small cell lung cancer.
    Livingston RB.
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):4-11; discussion 11-3. PubMed ID: 7973768
    [Abstract] [Full Text] [Related]

  • 23. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
    Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EE.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):515-22. PubMed ID: 17255273
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. New treatment agents for advanced small cell and non-small cell lung cancer.
    Bunn PA, Kelly K.
    Semin Oncol; 1995 Jun 15; 22(3 Suppl 6):53-63. PubMed ID: 7597434
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I.
    Cas Lek Cesk; 2005 Jun 15; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [Abstract] [Full Text] [Related]

  • 27. Daily paclitaxel and thoracic radiation therapy for non-small cell lung cancer: preliminary results.
    Rathmann J, Leopold KA, Rigas JR.
    Semin Radiat Oncol; 1999 Apr 15; 9(2 Suppl 1):130-5. PubMed ID: 10210552
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
    Wang WH, Bao Y, Chen M, Zhang L, Li KX, Xu GC, Deng XW, Lu TX, Cui NJ.
    Ai Zheng; 2006 Oct 15; 25(10):1279-83. PubMed ID: 17059776
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
    Crawford J.
    Semin Oncol; 1994 Oct 15; 21(5 Suppl 10):85-8. PubMed ID: 7526468
    [Abstract] [Full Text] [Related]

  • 33. Phase I study of concurrent real-time tumor-tracking thoracic radiation therapy with paclitaxel and carboplatin in locally advanced non-small cell lung cancer.
    Sakakibara-Konishi J, Oizumi S, Kinoshita I, Shinagawa N, Kikuchi J, Kato M, Inoue T, Katoh N, Onimaru R, Shirato H, Dosaka-Akita H, Nishimura M.
    Lung Cancer; 2011 Nov 15; 74(2):248-52. PubMed ID: 21397973
    [Abstract] [Full Text] [Related]

  • 34. Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.
    Tell R, Sederholm C, Klintenberg C, Franksson L, Brandén E, Hillerdal G, Lönn U, Lindén CJ, Ewers SB, Lamberg K, Mrazek E, Lödén B, Sjögren A, Linné T, Friesland S, Sirzén F.
    Anticancer Res; 2008 Nov 15; 28(5B):2851-7. PubMed ID: 19031924
    [Abstract] [Full Text] [Related]

  • 35. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
    Marks LB, Garst J, Socinski MA, Sibley G, Blackstock AW, Herndon JE, Zhou S, Shafman T, Tisch A, Clough R, Yu X, Turrisi A, Anscher M, Crawford J, Rosenman J, Carolina Conformal Therapy Consortium.
    J Clin Oncol; 2004 Nov 01; 22(21):4329-40. PubMed ID: 15514374
    [Abstract] [Full Text] [Related]

  • 36. Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent daily low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC).
    De Candis D, Stani SC, Bidoli P, Bedini VA, Potepan P, Navarria P, Aglione S, Bajetta E.
    Am J Clin Oncol; 2003 Jun 01; 26(3):265-9. PubMed ID: 12796598
    [Abstract] [Full Text] [Related]

  • 37. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy.
    Socinski MA.
    Clin Lung Cancer; 2004 Mar 01; 5(5):274-89. PubMed ID: 15086966
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
    Belani CP, Wang W, Johnson DH, Wagner H, Schiller J, Veeder M, Mehta M, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2005 Jun 01; 23(16):3760-7. PubMed ID: 15837967
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.